| EX0236 BRCA1 & BRCA2 MUTATION DRUG PROFILING PANEL |
| Specimen: |
Submit formalin-fixed paraffin-embedded Tissue Block. Ship at room temperature OR 4 mL (2 mL min.) Whole blood in 1 Lavender top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. |
| Stability: |
| Room |
Refrigerated |
Frozen |
| Ship at specified temperatures |
Ship at specified temperatures |
Ship at specified temperatures |
|
| Method: |
Next-Generation Sequencing |
| Comment: |
Genetic counseling will be provided with prior appointments. |
| Report: |
Contact us to know the TAT. |
| Usage: |
This assay detects most of the mutations and insertions/deletions in the BRCA gene which is linked to breast/ovarian cancer. Using the Oncomine Knowledge base, this assay predicts the response of drugs such as PARP inhibitors and helps to tailor the therapy. PARP inhibition results in selective killing of cancer cells that have lost BRCA1 or BRCA2 function. |
| Doctor Specialty: |
Oncologist |
| Disease: |
Cancer |
| Components: |
*BRCA 1 *BRCA 2 *Drug response |
| Courier Charges: |
|
| Home Collection: |
Available (*T&C Apply) |
| Department: |
MOLECULAR DIAGNOSTICS |
| Pre Test Information: |
A duly filled BRCA 1 & 2 informed consent form for genetic testing is mandatory. |
Reviews
There are no reviews yet.